Innovative diagnostic technologies are emerging to improve clinical decision-making and infectious disease management. Geneoscopy received FDA clearance for an updated stool collection kit improving ease of colorectal cancer screening, enhancing patient adherence. Aidoc clinched $150 million to advance its AI-powered clinical decision support systems used by over 150 health providers. Mirxes Japan partnered to provide free gastric cancer screening via miRNA blood tests. Advancements in RNA-based diagnostics and integration of biophysical approaches are forming a new frontier in medical testing protocols, supporting both individual care and broader epidemiological tracking.